| Date | Title | Company |
|---|
| 30 Aug 10 |
EndoGastric Solutions Completes $30 Million Financing Round |
Business Wire |
| 30 Aug 10 |
Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science |
PR Newswire |
| 30 Aug 10 |
Santarus Extends Maturity of $25 Million Revolving Line of Credit to July 2013 |
Business Wire |
| 30 Aug 10 |
KIKA Clinical Solutions Releases Veracity™ 3.10, Newest Version of its Advanced EDC Platform for Clinical Trial Management |
Business Wire |
| 30 Aug 10 |
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression |
Business Wire |
| 30 Aug 10 |
Katharine Spink, Geron to speak at Stem Cell Conference Oct 20-22, San Francisco |
GTCbio |
| 29 Aug 10 |
Sub-Analysis Shows Primary Benefits seen with RE-LY® are Independent of Level of Centre-Based International Normalized Ratio Control |
Business Wire |
| 29 Aug 10 |
New Global Campaign Aims to Prevent as Many as 1 Million Atrial Fibrillation-Related Strokes |
Business Wire |
| 28 Aug 10 |
Patrick Baeuerle as featured speaker at Cancer conference Oct. 20-22, 2010 CA-SF |
GTCbio |
| 28 Aug 10 |
BayBio Files Amicus Brief in Matrixx Case before the Supreme Court |
Business Wire |
| 28 Aug 10 |
Doug Holtz-Eakin speaks at Healthcare meeting Nov. 8-9, 2010, Washington DC |
GTCbio |
| 27 Aug 10 |
Connecting Healthcare Providers and Mobile Technology Conference |
Business Wire |
| 27 Aug 10 |
VertiFlex®, Inc. Announces Sale of Percutaneous Fusion Portfolio |
Business Wire |
| 27 Aug 10 |
Research and Markets: Novel Antibodies and Therapeutic Proteins - Technology Challenges and Future Prospects |
Business Wire |
| 27 Aug 10 |
Shire Announces European Approval of VPRIV® (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease |
|
| 27 Aug 10 |
Thermo Fisher Scientific Announces New UHPLC/MS Method for Sensitive, Precise and Reproducible Trace-Level Analysis of Perfluorinated Compounds in Human Breast Milk |
The Scott Partnership |
| 27 Aug 10 |
Maven Semantic: Nanotechnology Research Database |
Business Wire |
| 27 Aug 10 |
Biomagnetics Announces LOI to Acquire Hubei Tianyuan Chemical Company–Third Chinese Asset Targeted at $1.50 BMGP Share Price |
Business Wire |
| 27 Aug 10 |
Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment |
Business Wire |
| 27 Aug 10 |
Company Profile for Quintiles |
Business Wire |
| 27 Aug 10 |
Completed Preclinical Studies for a Novel Tritherapy that Temporarily Restores Basic Locomotor Activity after Spinal Cord Injury |
|
| 27 Aug 10 |
Recommendations for angiotensin receptor blockers updated in new NICE guidance on chronic heart failure |
|
| 27 Aug 10 |
Charles River Implements $300 Million Accelerated Stock Repurchase Program |
Business Wire |
| 27 Aug 10 |
Genentech Receives Refuse to File Letter from FDA for T-DM1 |
Business Wire |
| 27 Aug 10 |
Dorothee Foernzler at Roche to speak at Cancer Conference Oct 20-22 California |
GTCbio |
| 27 Aug 10 |
Genentech Provides Update on FDA Application for T-DM1 |
Business Wire |
| 27 Aug 10 |
Innovative Nutritional Hybrid Technology Introduced at USANA International Convention |
Business Wire |
| 27 Aug 10 |
First European Patent Claims Now Allowed for Microwave Peptide Synthesis |
Business Wire |
| 27 Aug 10 |
BioTime to Launch Seven New Embryonic Progenitor Cell Lines on September 1, 2010 |
Business Wire |
| 27 Aug 10 |
Research and Markets: Hyper pigmentation Therapy Area Pipeline Report 2010 Provides Insight into the Pipeline Status of Hyper Pigmentation Drugs |
Business Wire |
Resources |
Press Releases
